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Abstract 
Iron overload was developed in rats by ip injection of iron-dextran. Iron concentration i  plasma increased 12-fold after 20 h of iron 
supplementation a d unsaturated iron binding capacity (UIBC) drastically decreased in iron overloaded compared to control rats (69 + 36 
and 177 _+ 19/xg/dl, respectively). Lipid peroxidation i plasma increased by 285% and plasma a-tocopherol content decreased by 40% 
after 20 h of iron overload, a-Tocopherol supplementation decreased by 30% the measured increase in TBARS content in plasma after 
iron injection. On the other hand, both iron and TBARS content in erythrocytes were not significantly different in control and iron loaded 
rats. However, red blood cells from iron treated rats exposed to pro-oxidant conditions howed a significant increase in TBARS content as 
compared to control erythrocytes, a-Tocopherol pretreatment prevented this increase. Moreover, red blood cells from iron loaded rats 
showed a higher content of TBARS after incubation with plasma from iron-dextran i jected rats than after incubation with plasma from 
control animals. This measured increase was partially prevented by a-tocopherol supplementation. Neither the activity of antioxidant 
enzymes nor the content of a-tocopherol in red blood cells were affected by iron overload. Total thiols content was significantly lower 
(30%) in erythrocytes i olated from iron treated rats. The data presented here suggest that free radical generation catalyzed by metal ions 
may lead to consumption of thiols. The decrease in thiols content in erythrocytes could afford an appropriate degree of protection and 
avoid other oxidative damage to these cells. 
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1. Introduction 
Lipid peroxidation is an on-going physiological process 
which is important in the biosynthesis of prostaglandins 
and leukotrienes in cell membranes [1]. However, consid- 
erable evidence has emerged which strongly suggests the 
role of lipid peroxidation in the pathogenesis of many 
diseases [2]. Iron, by far the most abundant transition metal 
in the body, is an essential element for the utilization of 
oxygen, part of numerous oxidases, and oxygenases. It also 
plays a central role in generating harmful oxygen species 
and lipid oxidation [3]. Data are numerous which have 
established iron as an important component of lipid per- 
oxidation both in vitro and in vivo [4]. Normally iron is 
transported and stored in specific proteins (transferrin, 
lactoferrin, ferritin and haem proteins), which prevents or 
minimizes its reaction with oxygen derivatives [5]. How- 
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ever, in spite of these safeguards, increasing evidence 
suggests that reactive iron becomes ~vailable during some 
disease states [5]. 
Patients with hemochromatosis ( nlaerited iron overload) 
showed increased erythrocyte hemolysis [6], but direct 
evidence for increased lipid peroxidation in vivo remains 
to be demonstrated. Mammalian red blood cells are partic- 
ularly susceptible to oxidative damage because (i) being an 
oxygen carrier, they are exposed uninterruptedly to high 
oxygen tension, (ii) they have no capacity to repair their 
damaged components, and (iii) the haemoglobin is suscep- 
tible to autoxidation and their membrane components to 
lipid peroxidation [7]. Red blood celts, however, are pro- 
tected by a variety of antioxidant systems which are 
capable of preventing most of the adverse ffects of oxida- 
tive stress, under normal conditions [8]. The cell interior is 
rich in catalase, superoxide dismutase, glutathione, glu- 
tathione reductase and glutathione peroxidase and contains 
a proteolytic system that can hydrolyze oxidatively-mod- 
ified proteins [9]. A wide variety of oxidizing agents has 
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been used to induce changes in the structure and function 
of normal red blood cells. Incubation in vitro of red cells 
with trace metals such as copper and iron, causes hemoly- 
sis by interference with the generation of NADPH [10]. 
Moreover, it has been suggested that lesions in red blood 
cell membranes in thalassemia may result from extensive 
oxidative damage caused in part, by excess deposition of 
intracellular i on as ferritin and hemosiderin [11]. 
Plasma has been shown to possess powerful antioxidant 
activity, which is related to the function of plasma proteins 
[12]. Plasma antioxidant defense was suggested to be 
interrelated with that of red blood cells [13]. On the other 
hand, it seems highly likely that the essential requirement 
for iron storage in higher-life forms evolved closely along 
side antioxidant protection i volving safe iron-binding [ 14]. 
In the present study, an in vivo model of iron overload 
was developed by ip injection of iron-dextran and the 
effect on lipid peroxidation and antioxidant capacity was 
studied in plasma and isolated erythrocytes. Supplementa- 
tion of a-tocopherol before iron injection was tested as a 
possible protection agent against oxidative damage devel- 
oped by iron overdose. 
2. Materials and methods 
Male Wistar rats (200 g) were injected ip with iron-dex- 
tran (500 mg/kg body wt) [15]. a-Tocopherol (a-T) was 
administrated ip in a dose 100 mg/kg body wt, dissolved 
in 1 vol. of ethanol followed by the addition of 9 vol. 16% 
v /v  Tween-80 in 0.9% w/v  NaC1 [16], 1 h before iron-de- 
xtran injection. Control animals were injected with saline 
solution. 
Blood was withdrawn from the abdominal aorta under 
ether anaesthesia nd heparinized. Samples were cen- 
trifuged to separate plasma from the blood cells. Erythro- 
cytes were washed three times with 76 mM NaC1, 48 mM 
sodium phosphate, pH 7.4 [17]. 
Plasma iron and unsaturated iron-binding capacity 
(UIBC) were measured using the assay based on ferrozine 
[18] purchased from Sigma Diagnostics (Procedure N ° 
565). Erythrocyte iron content was determined spectropho- 
tometrically using bathophenanthroline [19] after treating 
the samples with HNO3-HCIO 4 (1:1) solution [20]. Yhio- 
barbituric acid reactive substances (TBARS) content was 
measured using a modified fluorescence method [21]. To 
0.5 ml of erythrocytes suspension (or 0.1 ml of plasma), 
0.05 ml of 4% w/v  BHT and 0.5 ml of 3% w/v  sodium 
dodecyl sulfate were added. After mixing, 2 ml of 0.1 N 
HC1, 0.3 ml 10% w/v  phosphotungstic a id, and 1 ml of 
0.7% w/v  2-thiobarbituric acid were added. The mixture 
was heated for 45 min in boiling water, and TBARS were 
extracted into 5 ml of n-butanol. After a brief centrifuga- 
tion, the fluorescence of the butanol layer was measured at 
515 nm excitation and 555 nm emission. The values were 
expressed as pmol TBARS (malondialdehyde equivalents) 
per mg of haemoglobin. Malondialdehyde standards were 
prepared from 1,1,3,3-tetramethoxypropane. 
Where indicated, erythrocytes were incubated as fol- 
lows: hematocrit was adjusted to 1-2% with 76 mM NaCI, 
48 mM sodium phosphate, pH 7.4. Ten ml of the erythro- 
cyte suspension were placed into 20 ml vials, and incu- 
bated at 37°C with constant shaking during 22 h [8]. 
Oxidative stress conditions were developed by incubation 
of the erythrocytes with either 2 mM ascorbate plus 0.17 
mM Fe-EDTA; 0.5 mM xanthine plus 30 mU/ml xanthine 
oxidase; 1 ml of control plasma or 1 ml of plasma from 
iron loaded rats. 
Superoxide dismutase activity in the erythrocytes was 
determined according to Flohe and Otting [22]. Previously, 
haemoglobin was removed by adding the same volume of 
cold chloroform/ethanol (1:2) with vigorous mixing and 
centrifuging at 5000 × g for 5 rain [23], to avoid possible 
interference. Glutathione peroxidase activity was deter- 
mined according to Pinto and Bartley [24]. Catalase activ- 
ity was determined according to Aebi [25]. a-Tocopherol 
(c~-T) content in plasma and erythrocytes was quantified 
by reverse-phase HPLC with electrochemical detection 
using a bioanalytical systems amperometric detector with a 
glassy-carbon working electrode at an applied oxidation 
potential of 0.6 V [26]. 
Erythrocyte total thiols content was determined accord- 
ing to Sies and Akerboom [27] monitoring the reduction of 
DTNB (5,5'-dithiobis (2-nitrobenzoic a id)). 
The buffers and the water used to prepare all solutions 
were passed through columns containing Chelex 100 resin 
to remove metal contaminants. Results are indicated as 
mean values +_ S.E.M. The one-way ANOVA test was 
used to determine statistical significance. 
3. Results 
Neither acute iron overload eveloped by iron-dextran 
treatment nor ip supplementation f c~-tocopherol (100 
mg/kg) 1 h before iron administration affected the 
hematocrit value (41 _+ 1 and 42 + 2% for control and iron 
overloaded rats, respectively). 
Iron concentration i plasma showed approx. 12-fold 
increase over the control values after 20 h of iron supple- 
mentation. A similar increase was measured 20 h after iron 
overdose in plasma of rats supplemented with a- 
tocopherol, compared to the appropriate control (Table 1). 
Unsaturated iron binding capacity (UIBC) (assessed as /xg 
of exogenous iron that can be taken by 100 ml plasma) 
was drastically decreased after iron-dextran i jection, sug- 
gesting that transferrin saturation was enhanced after the 
treatment (Table 1). 
TBARS content in plasma showed a 285% increase 
compared to control values 20 h after iron-dextran i jec- 
tion (Table 2). Iron administration after c~-tocopherol sup- 
plementation i creased by 200% the content of TBARS. 
M. Galleano, S. Puntarulo / Biochimica et Biophysica Acta 1271 (1995) 321-326 323 
Table 1 
Effect of iron-dextran treatment on plasma iron content 
Iron content (/xg/dl) UIBC (/xg/dl) 
Control 126 ± 20 177 ± 19 
Iron overload 20 h 1538+ 158 a 69±36 ~ 
Control + a-T 139 ± 6 162 ± 18 
Iron overload+ cr-T 20 h 1318+ 131 b 53+25 b 
UIBC stands for Unsaturated Iron-Binding Capacity. 
In each experiment 3 to 6 animals were used. The results are indicated as 
mean values ± S.E. of 3 to 4 independent experiments. 
Significantly different from the control group (P < 0.05). 
b Significantly different from the control + ~-T group (P < 0.05). 
The group that had received ce-tocopherol supplementation 
before iron dose showed a significant decrease (30%) 
respect o the group receiving iron-dextran, suggesting that 
the increase in vitamin E content could protect against 
lipid oxidation in vivo (Table 2). Over the 20 h period 
after iron overload, o~-tocopherol content in plasma of iron 
supplemented rats decreased significantly (40%), and this 
decrease was prevented by vitamin E administration (Table 
2). 
Total iron content measured in isolated red blood cells 
treated with HC104-HNO 3 did not show a difference be- 
tween control and iron overloaded rats (840 ± 40 and 
861 ± 91 /xg/mg Hb, respectively). Since total iron mea- 
surements in erythrocytes mostly reflect iron bound to 
haemoglobin, it has been described [28] that non-protein 
bound low molecular weight chelated iron (LMWC) could 
be estimated by lysing the red cells. Erythrocytes were 
added with 15% TCA and iron was measured in the 
supernatant. Non-significant differences have been found 
in LMWC of erythrocytes from control and iron over- 
loaded rats (60 ± 6 and 66 _+ 6 ng Fe /mg Hb, respec- 
tively). 
Endogenous TBARS content in red blood cells from 
control and treated rats did not show a significant differ- 
ence (Table 3), suggesting that erythrocytes could be resis- 
tant to the effect of oxidative stress conditions developed 
in the plasma by mild iron overload. To further explore the 
effect of iron supplementation red blood cells, TBARS 
content was measured after incubation in vitro of the 
erythrocytes during 22 h under several experimental condi- 
tions. Table 3 indicates that erythrocytes from iron over- 
Table 3 
TBARS content in erythrocytes: effect of in vitro incubation under 
oxidative stress conditions 
TBARS (pmol/mg Hb) 
Endogenous No addition Incubation a 
Fe/Asc X /XO 
Control 96+9 99_+ l~i 444+58 120_+ 11 
Iron overload 20 h 105±9 127±31 663±70 b 257±26 b 
Control+o~-T 105±8 126± 0 386±33 163±11 
Iron overload+ a-T 20 h 102±9 101±40 354+86 144±54 
Incubation of isolated erythrocytes was performed as indicated in 
Section 2, during 22 h. 
In each experiment 3 to 6 animals were used. The results are indicated as 
mean values + S.E. of 3 to 4 independent experiments. 
b Significantly different from the control group (P < 0.05). 
loaded rats showed an increased content of TBARS, com- 
pared to that found in red blood cells from control rats 
when they were exposed to oxygen radical generating 
systems, such as iron-ascorbate or xanthine-xanthine oxi- 
dase during 22 h. The amount of peroxides generated 
depend upon the incubation period qdata not shown). Pre- 
treatment in vivo with c~-tocopberol prevented the increase 
in TBARS verified in vitro. To resemble in vivo conditions 
both, control and iron overloaded e~2cthrocytes were incu- 
bated with either control or iron :~upplemented plasma. 
Table 4 shows that TBARS contem in erythrocytes from 
iron treated rats was higher when incubated in the presence 
of plasma from iron overloaded rats ~:han in the presence of 
control plasma; indicating the higher pro-oxidant capacity 
Table 4 
TBARS content of erythrocytes incubated in the presence of plasma 
TBARS (pmol/m~ Hb) 
+ Control plasma + Fe overloaded plasma" 
Control 111 -- 16 166 ± 31 
Iron overload 20 h 96 ± 5 206 ± 14 b 
Control + a-T 124 ± 15 179 ± 25 
Iron overload + a-T 20 h 89 ± 15 163 ± 18 b 
Plasma from Fe-dextran treated rats for 20 h. 
In each experiment 3 to 6 animals were used. The results are indicated as 
mean values _+ S.E. of 3 to 4 independent experiments. 
b Significantly different from the value obtained by incubating erythro- 
cytes from iron overloaded rats with control plasma (P < 0.05). 
Table 2 
Effect of iron-dextran treatment on TBARS and a-tocopherol content in plasma 
TBARS (nmol/l) o~-tocopherol (nmol/ml) 
Control 0.7 _+ 0.1 4.5 ± 0.3 
Iron overload 20 h 2.7 _+ 0.1 ~ (+ 285%) 2.7 _ 0.3 a ( -40%) 
Control + ~x-T 0.68 + 0.05 9.7 ± 0.4 
Iron overload + ot-T 20 h 2.04 4- 0.03 b (+200%) 8.9 _ 0.1 
Numbers between parentheses refer to the increase or decrease of the parameters a  percentages of their respective controls. In each experiment 3 to 6 
animals were used. The results are indicated as mean values ± S.E. of 3 to 4 independent experiments. 
Significantly different from the control group (P < 0.05). 
b Significantly different from the control + o~-T group (P < 0.05). 
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Table 5 
Effect of iron-dextran treatment on ant±oxidant capacity in erythrocytes 
Treatment SOD GPx Cat Total thiols " 
(U /g  Hb) (U /g  Hb) (U/mg nb) ( /xmol /mg Hb) 
Control 1420 + 89 405 ± 74 106 + 13 2.0 ± 0.2 
Iron overload 20 h 1353 ___ 72 514 __+ 54 112 + 13 1.3 -- 0.3 ~ 
Control + cr-T 1383 + 118 610 ± 23 116 ± 10 1.7 + 0.3 
Iron overload + a-T 20 h 1760 + 340 525 ± 17 108 ± 10 1.5 _+ 0.2 
a Total thiols are expressed as /xmol GSH equivalents/rag Hb. 
In each experiment 3 to 6 animals were used. The results are indicated as mean values _+ S.E. of 3 to 4 independent experiments. 
b Significantly different from the control group (P < 0.05). 
of the plasma from rats supplemented with iron-dextran 
than the plasma from control rats. However, TBARS con- 
tent in erythrocytes from control rats subjected to identical 
incubation conditions than erythrocytes from treated rats, 
did not show any significant difference. These data suggest 
that erythrocytes from iron overloaded rats showed a dif- 
ferential susceptibility to oxidative stress compared to 
control erythrocytes only when exposed to demanding 
conditions. 
Enzymatic and non-enzymatic defense systems were 
evaluated in erythrocytes after iron overload. The activities 
of the ant±oxidant enzymes superoxide dismutase, glu- 
tathione peroxidase, and catalase were not significantly 
affected by iron overdose, in the presence or absence of 
a-tocopheroi pretreatment (Table 5). a-Tocopherol content 
in the erythrocyte membranes did not change significantly 
during the initial 20 h after iron treatment (22 _+ 7 and 
27 _+ 7 pmol /mg protein in control and iron overloaded 
erythrocytes, respectively). Moreover, no alterations in 
those levels were detected after a-tocopherol pretreatment. 
The content of total thiols in red blood cells isolated from 
iron overloaded rats showed a 30% decrease compared to 
erythrocytes from control animals (Table 5). 
4. Discussion 
Therapeutic interventions involving the use of iron-de- 
xtran in patients with documented iron deficiency [29] 
increased the interest on the study of iron overload effects 
on blood. It has been proposed that the primary ant±oxidant 
defenses of plasma are mainly concerned with the inactiva- 
tion of redox active iron [3,30]. In plasma, most iron is 
bound to the iron carrying protein transferrin, but low 
molecular mass iron can become available, due to iron 
overload or during severe oxidative stress [3]. In the 
present study, unsaturated iron binding capacity (UIBC) 
was significantly decreased after 20 h of iron-dextran 
injection, suggesting an increased percentage of saturation 
in transferrin. Although less than 5% iron is not bound to 
transferrin under physiological conditions, in haemochro- 
matosis transferrin becomes fully saturated and non-trans- 
ferrin-bound iron (NTBI) may constitute up to 35% of the 
total serum iron [31]. Plasma devoid of any iron-binding 
and iron-oxidizing potential stimulates lipid peroxidation 
since NTBI is capable of generating free radicals which 
can initiate membrane damage [32]. In agreement with this 
hypothesis, TBARS content in plasma was increased by 
285% after iron overload. Increased levels of TBARS have 
previously been reported in patients with haemochromato- 
sis [33]. In our model of mild acute iron overload, besides 
the increased content in TBARS, a-tocopherol content in 
plasma was decreased by 40% after iron-dextran treatment. 
a-Tocopherol supplementation before iron overdose pre- 
vented the ant±oxidant decrease and limited up to 200% the 
increase of TBARS in plasma. 
In vitro studies showed that iron can stimulate the 
peroxidation of erythrocytes membrane lipids [1], changes 
in red cell morphology, alteration in the polypeptide pat- 
tern of membrane proteins, and increases in 
methaemoglobin [10]. On the other hand, exposure of 
erythrocytes to decreased a-tocopherol levels, such as in 
diabetics, lead to an increase in lipofuscin products [34]. 
Since red blood cells from iron overload rats are continu- 
ously being exposed to an increased iron content and a 
decreased level of a-tocopherol in the plasma, lipid per- 
oxidation in erythrocytes was evaluated. No significant 
differences were detected in red blood cells from control 
rats when compared to erythrocytes from iron overloaded 
rats, suggesting high resistance to oxidative stress of these 
cells. Incubation of isolated erythrocytes in the presence of 
either chemical or enzymatic radical generating systems, 
significantly increased TBARS content in iron overloaded 
red blood cells compared to control cells. These data 
suggest a differential ability in developing protection 
against oxidative damage between both groups of cells. To 
further explore the differential resistance between control 
and in vivo iron treated erythrocytes, incubation of the 
cells were performed in the presence of either control 
plasma or plasma from iron overloaded rats. Red blood 
cells from control rats exposed to plasma enriched in iron 
and with a low content of vitamin E (plasma from iron 
overloaded rats) showed a slight increase in TBARS con- 
tent (55 pmol /mg Hb) with respect o TBARS content in 
the erythrocytes after exposure to control plasma. This 
increase was significantly higher (110 pmol /mg Hb) for 
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erythrocytes from iron-dextran injected rats. This differ- 
ence suggests that even though under physiological condi- 
tions lipid peroxidation appears to be identical in control 
and treated cells, under more demanding conditions ery- 
throcytes from iron overloaded rats are more susceptible to 
develop damage. The supplementation with ce-tocopherol 
did not affect the relative increase in TBARS content in 
control red blood cells after exposure to control and iron- 
overloaded plasma (55 pmol /mg Hb). However, for iron 
overloaded cells this increase was significantly lower (74 
pmol /mg Hb) when supplementation with ce-tocopherol 
was performed. 
It has been well-recognized that vitamin E is essential 
for the integrity of red blood cells and it has been sug- 
gested that scavenging of free radicals by vitamin E is the 
first and most critical step in defending against oxidative 
damage to red blood cells [8]. Moreover, it has been 
postulated that both glutathione and ascorbic acid may 
complement the antioxidant functions of vitamin E by 
providing reducing equivalents necessary for its recy- 
cling/regeneration [35]. However, in our model of mild 
iron overload, neither ce-tocopherol content nor the activity 
of antioxidant enzymes (SOD, catalase, glutathione peroxi- 
dase) in red blood cells were affected in spite of the 
developing of oxidative stress conditions in plasma. 
It has been shown that glutathione is present within the 
erythrocytes in a dynamic state [36] and that the biosyn- 
thetic pathway in these cells is so active that it is estimated 
the erythrocyte can synthesize its entire glutathione content 
in about 10 min [37]. Dass et al. have suggested an 
important role for red blood cells as an additional compo- 
nent of glutathione homeostasis [38]. Moreover, it has been 
reported that chronic iron-loading of mice stimulates lipid 
peroxidation and oxidation of glutathione [39]. In our 
model of mild iron overload, a significant decline (30%) 
has been measured in total thiols content in erythrocytes. 
This finding suggest hat free radical generation catalyzed 
by metal ions may lead to glutathione consumption and 
that the alteration in the level of this antioxidant could 
maintain an appropriate degree of protection and avoid 
other oxidative damage to the cell. 
In the light of the present results, it could be postulated 
that iron overload leads to enhanced peroxidative decom- 
position of membrane lipids in erythrocytes only when the 
cells is partially depleted of glutathione due to an in- 
creased emand by stress conditions. The important role of 
glutathione as protector against iron-induced injury in red 
blood cells can be achieved by direct scavenging of radi- 
cals through a vitamin E dependent mechanism, preserving 
thiol-disulfide status of proteins or acting as an essential 
component in repairing oxidant damage. However, a com- 
plete understanding of the effects of tissue-specific patho- 
logical changes is critical before dietary or pharmacologi- 
cal interventions could be design to increase glutathione 
and/or c~-tocopherol levels for therapeutic purpose in 
acute iron overload. 
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